Nightingale Health Ltd. (JETRO Global Connection Zone)
- Area
- Co-Creation PARK (JETRO Global Connection Zone)
- hall
- hall8
- Booth Location
- C078-009
- Products
Medical & Healthcare
Exhibitor Information
We are a Finnish biotech company leading a movement to transform global health. Our goal is to enable preventive and personalized healthcare globally. We believe that rather than solely focusing on treatments, health should be about keeping people healthy. We develop pioneering solutions that facilitate active prevention of chronic diseases, such as heart disease and diabetes. Our novel blood testing technology helps to forecast health by revealing unique molecular insights that are invisible using standard tests. With this we can empower people to make positive changes to impact their health and prevent them from getting sick at all. In essence, we exist to enable people to live healthier lives.
Contact Information
PR Contact Information
Links
- URL 1
- https://bit.ly/2o8icwZ
"Finnish Blood Testing Startup Is Going Beyond the Theranos Dream" - an article published in the Forbes magazine explaining our technology and mission as well as the field we operate in
- URL 2
- https://nightingalehealth.com/healthcare
Insight into the service Nightingale Health provides
- URL 3
- https://nightingalehealth.com/about/news/14-new-biomarkers-that-can-predict-your-life-expectancy
This study, with the help of Nightingale Health’s blood analysis platform, was able to identify blood biomarkers that can predict a person’s mortality risk up to 10 years in advance
- URL 4
- https://bit.ly/2n9vvNU
Nightingale Health will analyse the biomarker profiles of 500,000 blood samples from UK Biobank, the world's largest health database
- URL 5
- https://bit.ly/2nhByzK
Nightingale collaborates with National University of Singapore to realise the prevention of chronic diseases in South East Asia
